A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/β-catenin Pathway

Kim Hei-Man Chow; Raymond Wai-Yin Sun; Janice B.B. Lam; Carrie Ka-Lei Li; Aimin Xu; Dik-Lung Ma; Ruben Abagyan; Yu Wang; Chi-Ming Che

doi:10.1158/0008-5472.CAN-09-3324

A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/β-catenin Pathway

Kim Hei-Man Chow, Raymond Wai-Yin Sun, Janice B.B. Lam, Carrie Ka-Lei Li, Aimin Xu, Dik-Lung Ma, Ruben Abagyan, Yu Wang^*, Chi-Ming Che^*

^*Corresponding author for this work

Department of Chemistry

Research output: Contribution to journal › Journal article › peer-review

97 Citations (Scopus)

Abstract

Gold(III) complexes have shown promise as antitumor agents, but their clinical usefulness has been limited by their poor stability under physiological conditions. A novel gold(III) porphyrin complex [5-hydroxyphenyl-10,15,20-triphenylporphyrinato gold(III) chloride (gold-2a)] with improved aqueous stability showed 100-fold to 3,000-fold higher cytotoxicity than platinum-based cisplatin and IC₅₀ values in the nanomolar range in a panel of human breast cancer cell lines. Intraductal injections of gold-2a significantly suppressed mammary tumor growth in nude mice. These effects are attributed, in part, to attenuation of Wnt/β-catenin signaling through inhibition of class I histone deacetylase (HDAC) activity. These data, in combination with computer modeling, suggest that gold-2a may represent a promising class of anticancer HDAC inhibitor preferentially targeting tumor cells with aberrant Wnt/β-catenin signaling.

Original language	English
Pages (from-to)	329–337
Number of pages	9
Journal	Cancer Research
Volume	70
Issue number	1
DOIs	https://doi.org/10.1158/0008-5472.CAN-09-3324
Publication status	Published - 1 Jan 2010

Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-09-3324

Cite this

@article{59aa01f63be044a88c7cd1bd769401c6,

title = "A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/β-catenin Pathway",

abstract = "Gold(III) complexes have shown promise as antitumor agents, but their clinical usefulness has been limited by their poor stability under physiological conditions. A novel gold(III) porphyrin complex [5-hydroxyphenyl-10,15,20-triphenylporphyrinato gold(III) chloride (gold-2a)] with improved aqueous stability showed 100-fold to 3,000-fold higher cytotoxicity than platinum-based cisplatin and IC50 values in the nanomolar range in a panel of human breast cancer cell lines. Intraductal injections of gold-2a significantly suppressed mammary tumor growth in nude mice. These effects are attributed, in part, to attenuation of Wnt/β-catenin signaling through inhibition of class I histone deacetylase (HDAC) activity. These data, in combination with computer modeling, suggest that gold-2a may represent a promising class of anticancer HDAC inhibitor preferentially targeting tumor cells with aberrant Wnt/β-catenin signaling.",

author = "Chow, {Kim Hei-Man} and Sun, {Raymond Wai-Yin} and Lam, {Janice B.B.} and Li, {Carrie Ka-Lei} and Aimin Xu and Dik-Lung Ma and Ruben Abagyan and Yu Wang and Chi-Ming Che",

note = "Funding Information: Grants from Seeding Funds for Basic Research of the University of Hong Kong (Y. Wang), Hong Kong Research Grant Council grants HKU 777908M (Y. Wang) and HKU 779707M (A. Xu), and the Area of Excellent Scheme AoE/P-10-01 established under University Grants Committee HKSAR (C. Che). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Publisher copyright: {\textcopyright} 2010 American Association for Cancer Research.",

year = "2010",

month = jan,

day = "1",

doi = "10.1158/0008-5472.CAN-09-3324",

language = "English",

volume = "70",

pages = "329–337",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

TY - JOUR

T1 - A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/β-catenin Pathway

AU - Chow, Kim Hei-Man

AU - Sun, Raymond Wai-Yin

AU - Lam, Janice B.B.

AU - Li, Carrie Ka-Lei

AU - Xu, Aimin

AU - Ma, Dik-Lung

AU - Abagyan, Ruben

AU - Wang, Yu

AU - Che, Chi-Ming

N1 - Funding Information: Grants from Seeding Funds for Basic Research of the University of Hong Kong (Y. Wang), Hong Kong Research Grant Council grants HKU 777908M (Y. Wang) and HKU 779707M (A. Xu), and the Area of Excellent Scheme AoE/P-10-01 established under University Grants Committee HKSAR (C. Che). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Publisher copyright: © 2010 American Association for Cancer Research.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Gold(III) complexes have shown promise as antitumor agents, but their clinical usefulness has been limited by their poor stability under physiological conditions. A novel gold(III) porphyrin complex [5-hydroxyphenyl-10,15,20-triphenylporphyrinato gold(III) chloride (gold-2a)] with improved aqueous stability showed 100-fold to 3,000-fold higher cytotoxicity than platinum-based cisplatin and IC50 values in the nanomolar range in a panel of human breast cancer cell lines. Intraductal injections of gold-2a significantly suppressed mammary tumor growth in nude mice. These effects are attributed, in part, to attenuation of Wnt/β-catenin signaling through inhibition of class I histone deacetylase (HDAC) activity. These data, in combination with computer modeling, suggest that gold-2a may represent a promising class of anticancer HDAC inhibitor preferentially targeting tumor cells with aberrant Wnt/β-catenin signaling.

AB - Gold(III) complexes have shown promise as antitumor agents, but their clinical usefulness has been limited by their poor stability under physiological conditions. A novel gold(III) porphyrin complex [5-hydroxyphenyl-10,15,20-triphenylporphyrinato gold(III) chloride (gold-2a)] with improved aqueous stability showed 100-fold to 3,000-fold higher cytotoxicity than platinum-based cisplatin and IC50 values in the nanomolar range in a panel of human breast cancer cell lines. Intraductal injections of gold-2a significantly suppressed mammary tumor growth in nude mice. These effects are attributed, in part, to attenuation of Wnt/β-catenin signaling through inhibition of class I histone deacetylase (HDAC) activity. These data, in combination with computer modeling, suggest that gold-2a may represent a promising class of anticancer HDAC inhibitor preferentially targeting tumor cells with aberrant Wnt/β-catenin signaling.

UR - http://www.scopus.com/inward/record.url?scp=75149132744&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-3324

DO - 10.1158/0008-5472.CAN-09-3324

M3 - Journal article

C2 - 19996284

AN - SCOPUS:75149132744

SN - 0008-5472

VL - 70

SP - 329

EP - 337

JO - Cancer Research

JF - Cancer Research

IS - 1

ER -

A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/β-catenin Pathway

Abstract

Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this